Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             43 results found
no title author magazine year volume issue page(s) type
1 Adolescents’ awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary Marek, Erika
 2011
 29 47 p. 8591-8598
8 p.
 article
2 Age-related changes in durability and function of vaccine-elicited influenza-specific CD4+ T-cell responses Mahnke, Yolanda D.
 2011
 29 47 p. 8606-8614
9 p.
 article
3 A heat shock protein based polyvalent vaccine targeting HSV-2: CD4+ and CD8+ cellular immunity and protective efficacy Mo, Annie
 2011
 29 47 p. 8530-8541
12 p.
 article
4 A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health Francis, Shelley A.
 2011
 29 47 p. 8760-8765
6 p.
 article
5 Bone marrow vaccination: A novel approach to enhance antigen specific antitumor immunity Fresnay, Stephanie
 2011
 29 47 p. 8599-8605
7 p.
 article
6 Bovine respiratory syncytial virus ISCOMs—Immunity, protection and safety in young conventional calves Hägglund, Sara
 2011
 29 47 p. 8719-8730
12 p.
 article
7 Burden and prevention of viral hepatitis in Bulgaria FitzSimons, David
 2011
 29 47 p. 8471-8476
6 p.
 article
8 Comparative evaluation of the antibody in lymphocyte supernatant (ALS) and enzyme-linked immunospot (ELISPOT) assays for measuring mucosal immune responses to Shigella antigens Feller, Andrea J.
 2011
 29 47 p. 8487-8489
3 p.
 article
9 Construction and immunogenicity of recombinant adenovirus expressing ORF2 of PCV2 and porcine IFN gamma Genmei, Liu
 2011
 29 47 p. 8677-8682
6 p.
 article
10 Economic evaluation of second generation pneumococcal conjugate vaccines in Norway Robberstad, Bjarne
 2011
 29 47 p. 8564-8574
11 p.
 article
11 Editorial Board 2011
 29 47 p. CO2-
1 p.
 article
12 Efficient induction of anti-tumor immunity by a TAT-CEA fusion protein vaccine with poly(I:C) in a murine colorectal tumor model Park, Jung-Sun
 2011
 29 47 p. 8642-8648
7 p.
 article
13 Exploiting mucosal surfaces for the development of mucosal vaccines Meeusen, Els N.
 2011
 29 47 p. 8506-8511
6 p.
 article
14 Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys Hu, Haixia
 2011
 29 47 p. 8624-8633
10 p.
 article
15 Humoral immune response of a pneumococcal conjugate vaccine: Capsular polysaccharide serotype 14—Lysine modified PspA Santamaria, Raquel
 2011
 29 47 p. 8689-8695
7 p.
 article
16 Identification and immunogenicity of Mannheimia haemolytica S1 outer membrane lipoprotein PlpF Ayalew, Sahlu
 2011
 29 47 p. 8712-8718
7 p.
 article
17 Identification of a new protective antigen of Bordetella pertussis Alvarez Hayes, Jimena
 2011
 29 47 p. 8731-8739
9 p.
 article
18 Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production Coussens, Paul M.
 2011
 29 47 p. 8661-8668
8 p.
 article
19 Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children Phongsamart, Wanatpreeya
 2011
 29 47 p. 8705-8711
7 p.
 article
20 Improved long-term protection against Mycobacterium tuberculosis Beijing/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens Reece, Stephen T.
 2011
 29 47 p. 8740-8744
5 p.
 article
21 Increased survival time in mice vaccinated with a branched lysine multiple antigenic peptide containing B- and T-cell epitopes from T. gondii antigens Wang, Yanhua
 2011
 29 47 p. 8619-8623
5 p.
 article
22 Intranasal Sendai viral vector vaccination is more immunogenic than intramuscular under pre-existing anti-vector antibodies Moriya, Chikaya
 2011
 29 47 p. 8557-8563
7 p.
 article
23 MAGE-A family: Attractive targets for cancer immunotherapy Sang, Meixiang
 2011
 29 47 p. 8496-8500
5 p.
 article
24 Missed clinical opportunities: Provider recommendations for HPV vaccination for 11–12 year old girls are limited Vadaparampil, Susan T.
 2011
 29 47 p. 8634-8641
8 p.
 article
25 Mucosal antibodies induced by tandem repeat of 2F5 epitope block transcytosis of HIV-1 Wang, Ji
 2011
 29 47 p. 8542-8548
7 p.
 article
26 Neuropathology of vaccination in infants and children Rorke-Adams, Lucy B.
 2011
 29 47 p. 8754-8759
6 p.
 article
27 Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera Draper, Eve
 2011
 29 47 p. 8585-8590
6 p.
 article
28 Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine Weston, Wayde
 2011
 29 47 p. 8483-8486
4 p.
 article
29 Planning for influenza vaccination in health care workers: An Intervention Mapping approach Kok, Gerjo
 2011
 29 47 p. 8512-8519
8 p.
 article
30 Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program Tanuseputro, Peter
 2011
 29 47 p. 8580-8584
5 p.
 article
31 Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles Zhao, Kai
 2011
 29 47 p. 8549-8556
8 p.
 article
32 Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination Winnock, M.
 2011
 29 47 p. 8656-8660
5 p.
 article
33 Rapid and accurate determination of the potency of varicella vaccine by quantitative polymerase chain reaction Russell, Marsha S.
 2011
 29 47 p. 8490-8495
6 p.
 article
34 Researching routine immunization–do we know what we don’t know? Clements, C. John
 2011
 29 47 p. 8477-8482
6 p.
 article
35 Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons Wald, Anna
 2011
 29 47 p. 8520-8529
10 p.
 article
36 Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO® Schuller, Elisabeth
 2011
 29 47 p. 8669-8676
8 p.
 article
37 Seasonal influenza vaccination in adults: Practice and attitudes about collaborative delivery with community vaccinators Hurley, Laura P.
 2011
 29 47 p. 8649-8655
7 p.
 article
38 Targeting the tick protective antigen subolesin reduces vector infestations and pathogen infection by Anaplasma marginale and Babesia bigemina Merino, Octavio
 2011
 29 47 p. 8575-8579
5 p.
 article
39 Therapeutic cancer vaccines: Why so few randomised phase III studies reflect the initial optimism of phase II studies Dalgleish, Angus G.
 2011
 29 47 p. 8501-8505
5 p.
 article
40 Trivalent and quadrivalent MF59®-adjuvanted influenza vaccine in young children: A dose- and schedule-finding study Della Cioppa, Giovanni
 2011
 29 47 p. 8696-8704
9 p.
 article
41 Universal peptide vaccines – Optimal peptide vaccine design based on viral sequence conservation Toussaint, Nora C.
 2011
 29 47 p. 8745-8753
9 p.
 article
42 Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media Seppälä, Elina
 2011
 29 47 p. 8615-8618
4 p.
 article
43 Wide-range protection against avian reovirus conferred by vaccination with representatives of four defined genotypes Lublin, Avishai
 2011
 29 47 p. 8683-8688
6 p.
 article
                             43 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands